Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bryn Mawr, PA
NPI
1760675714
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
919 Conestoga Rd Ste 311
Bryn Mawr, PA, 19010
Phone (610) 910-9104
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
1,686 services
Medicare patients, 2024
647
Average age 75
Drug cost, 2024
$2.5M
5,154 prescriptions
Company payments, 2025
$2,036
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denise Joffe was code 99215 (office e&m - established), 465 times for 334 patients. In total Denise Joffe billed 1,686 services in 16 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 465 | 334 | $130.32 | $61K |
| 99214 Office E&M - Established | Office | 408 | 347 | $103.32 | $42K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 329 | 276 | $12.72 | $4,185 |
| 95251 Test - Miscellaneous | Office | 191 | 106 | $26.80 | $5,120 |
| 99233 Hospital E&M - Subsequent | Facility | 118 | 70 | $95.22 | $11K |
| 99205 Office E&M - New | Office | 59 | 59 | $171.42 | $10K |
| 99223 Hospital E&M - Initial | Facility | 39 | 38 | $139.15 | $5,427 |
| 99204 Office E&M - New | Office | 28 | 28 | $128.90 | $3,609 |
| 83036 Blood Count | Office | 19 | 18 | $9.52 | $181 |
By year: 2022 $154K for 1,372 services; 2023 $157K for 1,360 services; 2024 $145K for 1,686 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 19 | 18 | $9.52 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Denise Joffe prescribed most often to Medicare patients was Levothyroxine Sodium, with 599 prescriptions and refills. In total Denise Joffe wrote 5,154 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 599 | 1,621 | 159 | $7,549 |
| Ozempic Semaglutide | 522 | 876 | 100 | $816K |
| Metformin Hcl Er Metformin Hcl | 368 | 1,035 | 117 | $5,886 |
| Mounjaro Tirzepatide | 276 | 349 | 50 | $356K |
| Synthroid Levothyroxine Sodium | 227 | 606 | 59 | $20K |
| Metformin Hcl Generic | 224 | 649 | 64 | $2,202 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 210 | 548 | 78 | $27K |
| Jardiance Empagliflozin | 189 | 410 | 51 | $235K |
| Tresiba Flextouch U-100 Insulin Degludec | 170 | 465 | 55 | $128K |
| Glimepiride Generic | 165 | 479 | 51 | $2,227 |
| Novolog Flexpen Insulin Aspart | 152 | 360 | 58 | $55K |
| Atorvastatin Calcium Generic | 149 | 437 | 47 | $2,528 |
| Farxiga Dapagliflozin Propanediol | 146 | 310 | 33 | $170K |
| Repaglinide Generic | 97 | 229 | 35 | $3,995 |
| Tresiba Flextouch U-200 Insulin Degludec | 93 | 208 | 26 | $99K |
Brand drugs: 2,585 claims; generic drugs: 2,200 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Denise Joffe $2,036 ($2,036 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbott Laboratories with $333.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 11 | $333 |
| Novo Nordisk Inc NVO | 14 | $289 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $182 |
| Lilly USA, LLC LLY | 10 | $172 |
| Amgen Inc. AMGN | 6 | $106 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $87.85 |
| Kyowa Kirin, Inc. 4151.T | 3 | $76.58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69.85 |
| Abbvie Inc. ABBV | 3 | $63.75 |
| Radius Health, Inc. | 2 | $59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.